Insider · CIK 0001624830
Charles S. Ryan
Files at QNCX (Quince Therapeutics, Inc.). First filing -, latest -.
Charles S. Ryan files SEC Form 4 as president at QNCX (Quince Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Charles S. Ryan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | QNCX Quince Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Jan 23, 2026 |
| Jun 18, 2025 | QNCX Quince Therapeutics, Inc. | AGrant or award Common Shares | +7,548 | $1.20 | $9,058 | 130,009 | Jun 23, 2025 |
| Jun 18, 2025 | QNCX Quince Therapeutics, Inc. | AGrant or award Warrantsderivative | +7,548 | $0.13 | $944 | 7,548 | Jun 23, 2025 |
Questions about Charles S. Ryan
Answered from the filings on this page, as of the latest one.
Is Charles S. Ryan buying or selling?
Charles S. Ryan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Charles S. Ryan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Charles S. Ryan has 0.
Where does Charles S. Ryan file Form 4?
Charles S. Ryan has filed Form 4 at QNCX (Quince Therapeutics, Inc.) as President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.